Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration
Cagdas Kaya,1 Souska Zandi,1,3 Isabel B Pfister,1,2 Christin Gerhardt,1,2 Justus G Garweg1,2 1Swiss Eye Institute, Rotkreuz, and Berner Augenklinik am Lindenhofspital, Bern, Switzerland; 2Department Ophthalmology, University Hospital Bern, Bern, Switzerland; 3Department of Ophthalmology, Inselspital...
Guardado en:
Autores principales: | Kaya C, Zandi S, Pfister IB, Gerhardt C, Garweg JG |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6edd1de197354931b6da13e16e01058e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Predictive Factors And Long-Term Visual Outcomes After Anti-Vascular Endothelial Growth Factor Treatment Of Retinal Angiomatous Proliferation
por: Maruyama-Inoue M, et al.
Publicado: (2019) -
Dexamethasone implant in the management of diabetic macular edema from clinician’s perspective
por: Urbančič M, et al.
Publicado: (2019) -
Macular edema resolution assessment with implantable dexamethasone in diabetic retinopathy (MERIT): a pilot study
por: Chhablani J, et al.
Publicado: (2018) -
Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda SM, et al.
Publicado: (2017) -
Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab
por: Nudleman E, et al.
Publicado: (2016)